Accelerating Medicines Partnership

International diabetes research knowledge portal opens

Thursday, October 8, 2015

Researchers funded by the NIH and the Foundation for the NIH (FNIH) have expanded a recently launched online library, called a knowledge portal, which allows open-access searching of human genetic and clinical information on type 2 diabetes. Individual data will remain confidential. The portal includes information from several major international networks, collected from decades of research.

[Read More]

NIH-led effort launches Big Data portal for Alzheimer’s drug discovery

Friday, March 6, 2015

A NIH-led public-private partnership to transform and accelerate drug development has launched a new Alzheimer’s Big Data portal—including delivery of the first wave of data—for use by the research community. The new data sharing and analysis resource is part of the Accelerating Medicines Partnership (AMP), an unprecedented venture bringing together NIH, FDA, industry and academic scientists from a variety of disciplines to translate knowledge faster and more successfully into new therapies.

[Read More]

Report: U.S. biopharma companies currently developing 182 diabetes treatments

Wednesday, February 19, 2014

America’s biopharmaceutical research companies currently are developing 182 innovative new medicines to help the nearly 400 million people who have diabetes worldwide. These medicines in development—all either in clinical trials or under review by the FDA—include 30 for type 1 diabetes, 100 for type 2 and 52 for diabetes-related conditions, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

[Read More]